SCHEMBL22472385

SCHEMBL22472385

Cc1ccc2c(oc3nc4ccccc4n32)c1-c1ccc(-c2c(-c3ccccc3)c(-c3ccccc3)c(-c3ccccc3)c(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.40
HSD17B10 Q99714 5/20 0.39
POLB P06746 4/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MDM2 Q00987 1/20 0.39
KDM4E B2RXH2 11/20 0.39
ALDH1A1 P00352 9/20 0.39
HPGD P15428 8/20 0.39
LMNA P02545 5/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
GAA P10253 4/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TP53 P04637 2/20 0.37
NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22472452 0.93 KDM4E (0.40) ADORA2AHSD17B10POLBKMT2AMEN1
SCHEMBL22472388 0.84 KDM4E (0.34) ADORA2AHSD17B10POLBKMT2AMEN1
SCHEMBL22472396 0.80 ALDH1A1 (0.34) ADORA2AHSD17B10POLBKMT2AMEN1
SCHEMBL22472391 0.78 MAT2A (0.33) ADORA2AHSD17B10KMT2AMDM2ALDH1A1
SCHEMBL22472471 0.78 ALDH1A1 (0.38) ADORA2AHSD17B10POLBKMT2AMEN1
SCHEMBL20041634 0.78 TSHR (0.41) HSD17B10POLBKMT2AMEN1KDM4E
SCHEMBL22472593 0.77 NPC1 (0.32) KDM4EALDH1A1HPGDLMNANPSR1
SCHEMBL17507336 0.76 HPGD (0.40) ADORA2AHSD17B10POLBKMT2AMEN1
SCHEMBL17507333 0.75 HPGD (0.42) ADORA2AHSD17B10POLBKMT2AMEN1
SCHEMBL22472394 0.74 NPC1 (0.42) ADORA2AHSD17B10POLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10790455-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10790455-B2 Organic electroluminescent materials and devices ORC3, ALKBH2, ENPP3 ADORA2A 1716/4885HSD17B10 3085/4885POLB 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.